JGC
DVAX

J. Goldman & Co’s Dynavax Technologies DVAX Stock Holding History

J. Goldman & Co’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,269
Closed -$455K – 260
2015
Q1 		$455K Buy
+20,269
New +$388K 0.03% 251

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

J. Goldman & Co's DVAX Position: Q2 2015 in Review

J. Goldman & Co sold out of Dynavax Technologies (DVAX) in Q2 2015, closing a stake of 20,269 shares — an estimated $455K sold.

J. Goldman & Co first reported a position in DVAX in Q1 2015 and held it in 1 quarter. The position peaked at $455K in Q1 2015. 120 funds tracked by Wall St. Rank hold DVAX as of Q2 2015.

  • J. Goldman & Co reported no remaining Dynavax Technologies position as of Q2 2015 after selling out during the quarter.
  • J. Goldman & Co sold 20,269 Dynavax Technologies shares in Q2 2015, an estimated $455K.
  • J. Goldman & Co first reported a position in Dynavax Technologies in Q1 2015 and held it in 1 quarter.
  • J. Goldman & Co's Dynavax Technologies position peaked at $455K in Q1 2015.
  • 120 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2015.

Based on J. Goldman & Co's 13F filing for Q2 2015, filed 14 Aug 2015.